Skip to main content
. 2020 May 11;8:100047. doi: 10.1016/j.ynpai.2020.100047

Fig. 5.

Fig. 5

WIN55 Attenuates Pain in Phase II of the Formalin Test. The CB1r agonist WIN55 (3 mg/kg) attenuates the behavioral responses induced by formalin in both Phase I (A) and Phase II (B) for mice, but only Phase II for naked mole-rats. (n = 8; * p < 0.05, ** p < 0.01, Statistical analysis was performed using a paired T-test).